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Summary 
Aims: To clarify the mechanism how CD206+ M2-like macrophages in adipose tissue regulate 
adipocyte progenitors proliferation to induce insulin sensitivity. Methods: I generated transgenic 
mice to specifically ablate CD206-positive cells utilizing a conditional cell ablation system based 
on the transgenic expression of the human diphtheria toxin receptor under the control of CD206 
promoter. I also generated genetically engineered CD206CreERT2/TGFflox/flox (TGF KO) 
mice to specifically delete TGF in CD206+ cells.  Results: Current study show that CD206+ 
M2-like macrophages in adipose tissue regulate systemic glucose homeostasis by inhibiting 
adipocyte progenitor proliferation via the CD206/TGFβ signaling pathway. Current study reveals 
that adipose tissue CD206+ cells are primarily M2-like macrophages, and ablation of 
CD206+ M2-like macrophages improves systemic insulin sensitivity, which was associated with 
an increased number of smaller adipocytes. Mice genetically engineered to have reduced 
numbers of CD206+ M2-like macrophages show a down-regulation of TGFβ signaling in adipose 
tissue, together with up-regulated proliferation and differentiation of adipocyte progenitors. 
Conclusion: Our findings indicate that CD206+ M2-like macrophages in adipose tissues create a 
microenvironment that inhibits growth and differentiation of adipocyte progenitors and, thereby, 
control adiposity and systemic insulin sensitivity. Inhibition of CD206+ M2-like macrophages 
may be a new therapeutic target for maintaining systemic energy and glucose metabolism. 
 
Keywords;  
Insulin resistance, adipocyte progenitors, adipose tissue macrophages, and obesity. 
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1.0 Introduction 
White adipose tissue (WAT) markedly adapts to nutrient excess through adipocyte 
hypertrophy and hyperplasia [1-3]. The WAT expansion greatly affects the pathogenesis 
of obesity through different cellular mechanisms [4]. Adipocyte size is inversely related 
to insulin resistance [5], whereas the number of adipocytes is related to the pool size of 
adipocyte progenitors (APs). Several groups, including our laboratory, have reported 
that M1-like inflammatory macrophages regulate the expression of angiogenic genes in 
preadipocytes [3, 6], suggesting interactions between macrophages and APs. It is still 
unknown how the proliferation and differentiation of APs are regulated by M2-like 
macrophages within WAT, thus controlling the insulin sensitivity. Adipose tissue 
resident macrophages (ATMs) play an important role in both tissue remodeling/repair 
and maintenance of insulin sensitivity via their anti-inflammatory actions [1-3, 7, 8]. 
Adipose tissue markedly developed adipocyte hypertrophy and hyperplasia to adapts 
against nutrient surplus [9, 10]. A recent study indicates that tissue-resident M2-like 
macrophages are involved in clearance of apoptic cells and recruitment of APs after 3 
agonist treatment [11]. Congenital deficiency of M2-like macrophages reportedly causes 
lipodystrophy-like pathophysiology accompanied by accelerated lipolysis [12]. As 
insulin resistance and obesity related disorders progresses with advance age and 
2 
 
M2-like macrophages also upregulated at the early phase of obesity [13]. Nonetheless, 
whether and how macrophages participate in adipogenesis during remodeling and repair 
remain largely unknown. Recently, adipose tissue inflammation considered to be 
important factor for the progression of obesity and type 2 diabetes [1, 14-18]. Adipose 
tissue inflammation results in the expansion of AT involved in the progression of 
obesity related disorders [19].  
Obesity, defined as an excessive increase in WAT, is a global health epidemic. In 
obesity, WAT expands because of increases in adipocyte size (hypertrophy) and number 
(hyperplasia). Obesity is associated with a phenotypic transformation of macrophages, 
from anti-inflammatory M2 to pro-inflammatory M1-like macrophages, thereby causing 
insulin resistance [1, 20, 21]. We and other groups have shown that in lean state, the 
majority of macrophages in the white adipose tissue is M2-type while in obese state, the 
majority of macrophages that infiltrate WAT is M1-type. These adipose 
tissue-infiltrating M1-like macrophages are known to be responsible for persistent 
low-grade inflammatory state which underlies the systemic insulin resistance in obesity. 
It has been known that M2-like macrophages are required for the maintenance of 
homeostasis, tissue remodeling and metabolic adaptation under nutrient surplus 
conditions. However, the role for adipose tissue-resident M2-like macrophages in lean 
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states remains elusive.  
In obese adipose tissue, hypoxia has been shown to induce the stimulation of 
hypoxia-inducible factor-1 (HIF-1) [22, 23]. Hypoxic environment causes its HIF-1α 
subunit to translocate from cytoplasm to the nucleus, where it dimerize with its HIF-1β 
subunit and certain co-activators interact with its transactivation domain and results in 
the transcription of many genes regulating different processes including angiogenesis 
and glucose metabolism [24]. 
Hypoxic responses mediated by HIF-1α affect the adipocytes and macrophages 
differentially. In adipocytes HIF-1α has been shown to cause the metabolic dysfunction 
followed by proinflammatory response as reported in several transgenic mice studies 
[23, 25-29]. With regard to the role of macrophage HIF-1α we hypothesized that there 
are two possibilities about the dual character of macrophage HIF-1α. The first 
possibility is that macrophage HIF-1α is involved in proinflammatory responses [30, 
31], thereby causing the adipose tissue inflammation and systemic insulin resistance. 
The other possibility is that ATMs secrete proangiogenic genes such as vascular 
endothelial growth factor (VEGF), basic fibroblast growth factor, as reported in 
tumor-associated macrophages (TAMs) [32] under hypoxic conditions, thus providing 
adipocytes with vascular network to improve adipocyte metabolism.  
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Adipose vasculature is regulated by various proangiogenic factors released from 
adipocytes and other cells in the stromal vascular fraction (SVF) such as macrophages, 
preadipocytes and endothelial cells. Production of these factors may be impaired in 
pathological expansion of adipose tissue. There are several pieces of evidence pointing 
towards the positive role of adipocyte-derived VEGF in inducing the healthy expansion 
[33]. Under the obese state, the expressionof VEGF gene is not sufficiently induced [31], 
which may be partly due to the fact that adipocyte HIF-1α is not a strong inducer of 
VEGF gene expression. In addition adipocyte HIF-1α not only failed in inducing the 
adequate angiogenesis but was involved in the induction of fibrosis through increased 
formation of extracellular matrix components (ECM) [23]. On the other hand, ATMs 
express the VEGF gene via HIF-1α in response to adipose tissue hypoxia. Moreover, 
differentiating predipocytes produce high level of a range of proangiogenic factors, 
including fibroblast growth factor 2 (FGF-2), VEGF, hepatocyte growth factor (HGF) 
and PDGFs [34]. An early study showed that differentiation from preadipocytes to 
mature adipocytes was concomitantly linked to elevated production of angiogenic 
factors [35]. 
Recently, we determined the role of M1-like macrophages hypoxia-inducible 
factor-1α (HIF-1α) in adipose tissue of obese mice by generating myeloid cells 
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(macrophages) specific HIF-1α KO mice. HIF-1α in adipocytes reportedly induces 
oxidative stress and fibrosis, which contribute to the development of insulin resistance 
and type 2 diabetes. We reported that macrophages in crown-like structures (CLSs) are 
both hypoxic and inflammatory. In the present study, we examined how macrophage 
HIF-1α is involved in high-fat diet (HFD)-induced inflammation, and insulin resistance, 
using mice with myeloid cell-specific HIF-1α deletion fed an HFD. Myeloid 
cell-specific HIF-1α gene deletion protected against HFD-induced inflammation, CLS 
formation, poor vasculature development in the adipose tissue, and systemic insulin 
resistance. Thus, HIF-1α in myeloid cells is involved in not only the formation of CLSs, 
further enhancing the inflammatory responses, to promote insulin resistance (Figure 1). 
We concluded that these two pathways contribute to the obesity-related physiology of 
pathological adipose tissue expansion, thus causing systemic insulin resistance [6].  
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    In the subsequent study, I focused on the relationship between adipocytes and 
adipose tissue-resident macrophages (M2-like ATMs) in the situation of obesity and 
type 2 diabetes. There are two types of macrophages present in adipose tissue i.e. M1 
and M2-type. M1-type macrophages increase in obesity and are suggested to be 
involved in the development of type 2 diabetes, while little is known about the role of 
M2-like macrophages during obesity. M2-like macrophages are required for 
maintenance of homeostasis, tissue remodeling and metabolic adaptation under nutrient 
surplus conditions [36, 37], but it is largely unknown how macrophages participate in 
progenitor activation and adipogenesis.  
TGFβ and related factors control the development, growth and function of diverse 
cell types. TGFβ is often secreted by niche cells, thereby inducing hibernation of tissue 
stem cells such as hematopoietic and melanocyte stem cells [38, 39]. WAT-derived 
TGFβ1 reportedly contributes to insulin sensitivity, while blockade of TGFβ/smad 3 
signaling induces browning to protect against obesity and diabetes [40]. Adipose tissues 
of obese mice and humans showed higher TGFβ1 expression [41-43]. It is known that 
TGFβ signaling is involved in the maintenance of quiescence of hematopoietic stem 
cells and melanocyte stem cells. Nonmyelinating Schwann cells or follicular 
keratinocyte stem cells of the bulge area constitute a niche via TGFβ signaling. 
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It is known that TGFβ inhibits the differentiation of 3T3L1 cells [44]. Since 
M2-like macrophages reportedly express TGFβ at a high level, we hypothesized that 
CD206+ M2-like macrophages would provide a niche for APs via TGFβ signaling.  
To investigate the involvement of M2-like macrophages in the regulation of 
adipose tissue dynamics during metabolism-associated remodeling/repairing, we looked 
for a specific marker for M2-like ATMs. We have previously shown that the vast 
majority of macrophages in adipose tissue are CD206+ M2-like macrophages [13], but 
the ratio of CD206+ M2-like macrophages in F4/80-positive macrophage and 
F4/80-negative non-macrophage populations was not evaluated. As we previously 
reported, ATMs consist of two distinct populations: CD11c(+) M1 ATMs and CD206 
(+) M2 ATMs. Flow cytometric analyses indicated that CD11c+CD206- fractions are 
characterized by their M1 macrophage marker-dominant gene expression profiles while 
CD11c-CD206+ fractions are characterized by their M2 macrophage marker-dominant 
genes expression profiles. Genes that are predominantly expressed in M2-like 
macrophages in lean states include CD206, Arg1, IL-10 etc, while those in M1-like 
macrophages in obese states include CD11c, IL-6, TNFa, MCP1 etc. However, the 
precise mechanism how adipose tissues regulate glucose metabolism has not yet 
completely been understood. We first examined whether CD206-positive cells in the 
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adipose tissue in lean mice were indeed M2-like macrophages. To answer this question, 
we assessed the two critical points: Do F4/80 negative non-macrophage populations 
possibly express CD206 or are there any F4/80 macrophages that are negative for 
CD206. To address these issues, we collected SVF populations from epididymal WAT 
(eWAT) and subjected them to flow cytometric analysis. Cells were gated on 
CD45-positive cells and expression of CD206 and F4/80 on these cells were analyzed. 
Flow cytometry analysis showed that the almost all CD206-positive populations are 
F4/80-positive (Figure 2a and 2b), indicating that CD206+ M2-like macrophages in 
adipose tissues are macrophages, but not cells of other lineages. Flow cytometric 
analyses of eWAT of lean mice clearly showed that CD206 is a specific marker for 
adipose tissue-resident macrophages (M2-like ATMs). Consistently, F4/80 mRNA 
expression levels in F4/80+CD206+ populations compared to those in total SVF 
populations (Figure 1c, black/blue ratios) were equivalent to the relative levels of the 
well-characterized M2-like macrophage markers CD163, and Mgl2. We determined that 
the F4/80+CD206- population expressed higher level of CD11c, TNFa, IL-6, Zbtb46 
mRNA (Figure 2b, red) than the F4/80+CD206+ population, indicating that the former 
includes substantial amounts of M1-like macrophages and dendritic cells. In any event, 
CD206+ populations, which comprise the major population in ATMs, are exclusively 
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M2-like macrophages and not M1-like macrophages or non-macrophage populations. 
Thus, CD206 provides an ideal marker to target M2-like macrophages in adipose tissue. 
11 
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Figure 2. Specificity of CD206
+
 M2-like macrophages  
(a) Representative flow cytometry analysis of F4/80 and CD206 expression in the SVF 
of eWAT from WT mice (n=4-5). (b) Relative mRNA expression of SVF and 
FACS-sorted F4/80+CD206+ from eWAT of WT mice. Sorted cell populations based on 
the expression of CD206 and F4/80 on the SVF CD45+ cells from eWAT of NC mice 
(n=4-5 mice per group). The data are shown as the means ± SEM.  *P < 0.05 
compared with SVF by ANOVA. 
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In the current study, we have successfully performed partial but specific depletion 
of CD206+ M2-like macrophages without affecting either the number or functions of 
M1-like macrophages, and without affecting body weights or overall adiposity. We 
show that CD206+ M2-like macrophages play pivotal roles in WAT remodeling by 
modulating APs proliferation and differentiation into adipocytes through TGFβ 
signaling, providing a niche for APs. We further determined the specific involvement of 
CD206+ M2-like macrophages in terms of insulin sensitivity and adipose tissue 
remodeling both under normal chow (NC) and HFD-fed conditions. Thus, CD206/TGFβ 
signaling is pivotal players in modulating APs proliferation and differentiation to adjust 
adiposity and systemic insulin sensitivity.  
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2.0    Aims 
 
To clarify the mechanism how CD206+ M2-like macrophages in adipose tissue 
regulate adipocyte progenitors proliferation to induce insulin sensitivity. 
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3.0 Methods/Experimental procedures 
3.1 Creation of CD206DTR mice 
We recently reported that CD206+ M2-like macrophages were selectively 
depleted in CD206DTR mice, in which a human diphtheria toxin receptor (DTR) 
expression unit was knocked in at the CD206 promoter locus [45] (Figure 3a). Confocal 
imaging analysis shows that DTR was expressed only in CD206DTR mice while WT 
mice do not express DTR, showing specific co-localization with CD206-positive cells 
in eWAT (Figure 3b), which was not seen in wild type littermates. The CD206DTR and 
wild-type (WT) mice showed similar body weights during the observation period from 
6–14 weeks of age in the absence of diphtheria toxin (DT) (Figure 3c).  
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(a) Schematic representation of creation CD206DTR mice. Depletion of 
CD206-positive cells by DT administration. (b) Confocal immunofluorescence 
double staining of DTR and CD206 in eWAT. (c) Body weight changes of 
CD206DTR mice and WT littermates (n=3-5 mice per group). The data are shown 
as the means ± SEM.  *P < 0.05 compared with littermate by Student's t-test. 
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3.2 Generation and maintenance of mice 
To generate CD206DTR mice, we obtained mouse BAC clone RP 24-377 
D19 carrying a 152-kbp insert containing the exon coding translational Start Met 
and the upstream 133-kbp sequence of the CD206 gene from the BACPAC 
Resources Center CHORI (Oakland, CA). The plasmid pTRECK6, which includes a 
noncoding exon and intron from rabbit -globulin gene, human HB-EGF (DTR) 
cDNA, and rabbit -globulin and simian virus 40 polyadenylation signals, was 
kindly provided by Dr. Kenji Kohno (Nara Institute of Science and Technology). 
Using a Counter-selection BAC modification kit (Cat# K002) (Gene Bridges, 
Dresden, Germany), we removed 6-bp nucleotides (5ʹ-GTTATG-3ʹ; ATG 
corresponding to translational start Met of CD206) and inserted a 2.3-kbp fragment 
containing part of the noncoding exon and intron of the rabbit -globulin gene, DTR 
cDNA, and the polyadenylation signals from pTRECK6 to yield the BAC vector 
pTg-CD206DTR. The purified BAC DNA was microinjected into pronuclei of 
fertilized one-cell embryos from C57BL/6 mice by UNITECH (Chiba, Japan). The 
transgenic founders were then again backcrossed to C57BL/6 mice. The male F4 
generations and beyond were used for experiments to derive the data. Wild-type 
littermates were used as controls in all the experiments.  
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To generate CD206-CreERT2 mice, we created the targeting construct. The 
plasmid pCAG-CreERT2 was obtained from Addgene (# 14797). We replaced the 
human DTR DNA fragment in the pTg-CD206-DT receptor BAC transgene17 with 
mutated estrogen receptor fused Cre recombinase (CreERT2) DNA fragment in the 
pCAG-CreERT2 by using a Counter-selection BAC52 modification kit (Gene 
Bridges, Dresden, Germany) to yield the pTg-CD206-CreERT2 (CD206-CreERT2). 
In one series of experiments, we crossed male CD206-CreERT2 mice with female 
TGFflox/flox to obtain CD206-CreERT2/TGFflox/flox. Male CD206-CreERT2/ 
TGFflox/flox and control littermate TGFflox/flox were administered tamoxifen 
(0.15mg/gBW) for four consecutive days. Male Pdgfr-CreERT2-Egfp (PRa) mice 
were obtained from department of pathology, University of Toyama. Mice were 
maintained under standard 12h light and dark cycles. Male mice aged 8–12 weeks 
were used for all the experiments; the mice were allowed ad libitum access to water 
and standard chow (Nosan Corporation, Yokohama, Japan). For body weight and 
food intake measurements, the mice were caged individually. All the animal studies 
were conducted at the animal facility centre of the University of Toyama. Animal 
care and procedures were approved by the Animal Experiment Committee of the 
University of Toyama (Authorization No. S2009 Med-41). 
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3.3 Genotyping 
Whole genomic DNA was derived from the tail after lysing with 
DirectPCR(Tail) lysing solution from Viagen (Los Angeles, CA), according to the 
manufacturer’s instructions. This crude DNA was then used for PCR using the Tks 
Gflex DNA Polymerase kit from TaKaRa (Shiga, Japan), according to the 
manufacturer’s instructions and the following PCR conditions: one cycle of 95°C 
for 5 minutes, 35 cycles of 94°C for 30 seconds, 60°C for 30 seconds, and 72°C for 
30 seconds, and one cycle of 72°C for 7 minutes. The primers used for genotyping 
were purchased from InvitrogenTM Life Technology (Tokyo, Japan) and had the 
following sequences: primer 1, TGTATTCTTTGCCTTTCCCAGTCTC (CD206 
primer); primer 2, CCTCAA AACAGACTTACCCAATAGCTG (CD206 primer); 
primer 3, AAGAGGAGACAATG GTTGTCAACAG (DTR specific primer). The 
PCR products were subsequently separated using 1.5% agarose gel electrophoresis 
for 30 minutes. The DNA was visualized in the gel by the addition of ethidium 
bromide (1:1000 dilution) to the gel solution. The expected sizes of the DNA 
fragments for CD206 and CD206 DTR were 138 bp and 257 bp, respectively. 
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3.4 Realtime polymerase chain reaction (RT-PCR) 
Tissues for RT-PCR were collected and preserved in RNA later solution from 
Ambion (Austin, Texas) according to the manufacturer’s instructions. Tissue RNA 
was extracted using an RNeasy kit, cat# 74106 (Qiagen, Hilden, Germany) and was 
reverse transcribed using TaKaRa PrimeScript RNA Kit, cat# RR036A (Shiga, 
Japan), according to the manufacturer’s instructions. Quantitative PCR (qPCR) of 
the genes was performed using the TaqMan method (1 cycle of 50°C for 2 minutes, 
95°C for 10 minutes, and 40 cycles of 95°C for 15 seconds, 60°C for 1 minute) 
using premade primer sets. The relative mRNA expression levels were calculated 
using the standard curve method and were normalized to the mRNA levels of 18S or 
TF2B. The SYBR Green thermal cycling conditions were 1 cycle of 95°C for 30 
seconds, and 45 cycles of 95°C for 10 seconds and 60°C for 20 seconds. The 
relative mRNA expression levels were calculated using the standard curve method 
and were normalized to the mRNA levels of β-Actin, 18S or TF2B. 
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3.5 Diphtheria toxin injection 
Diphtheria toxin was diluted with sterile PBS(-) to the desired concentrations 
and was intraperitoneally injected at a dose of 3 ng/gram body weight 3–4 times 
every other day. The experiments and procedures were performed within two days 
after the last injection. 
3.6 Western blot  
Tissues for the western blot analysis were quickly frozen in liquid nitrogen 
and preserved at -80°C until utilization. The western blot analysis was performed as 
described previously with a slight modification [6]. Briefly, the tissues for western 
blotting were homogenized in lysis buffer containing 25 mM Tris-HCl (pH 7.4), 10 
mM Na3VO4, 100 mM NaF, 50 mM Na4P2O7, 10 mM EDTA, 0.2% leupeptin (5 
mg/mL), 0.5% aprotinin (5 mg/mL), 2 mM phenylmethylsulfonyl fluoride, and 1% 
Nonidet P-40 using a Multi-Beads ShockerTM cell disrupter. The lysates were 
centrifuged to remove any insoluble materials. The lysates were mixed with loading 
buffer before protein denaturation by boiling at 95°C for 3-5 minutes. The protein 
lysates were run on 7.5% separating gels and transferred afterwards to PVDF 
Immobilon-P transfer membranes (Millipore, Billerica MA). The membranes were 
incubated overnight at 4°C for the primary antibody (1:1000 dilution) and for 1 hour 
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at room temperature for the second antibody (1:2000 dilution) before being 
subjected to a western blot detection reagent immediately before image 
development. 
3.7 Immunohistochemistry 
Paraffin-embedded tissues were cut 5-μm thick and mounted on slides. Slide 
staining with the first and second antibodies was performed according to the 
manufacturer’s instructions. A specific cell count was performed for at least three 
randomly chosen 200x magnification fields. The average adipocyte size was 
measured by dividing the surface area of a 100x magnification field by the number 
of adipocytes. For BrdU staining, the mice were injected with 2 mg of BrdU 2 hours 
later, the mice were sacrificed and the tissues were collected for 
immunohistochemistry. 
In vitro immunohistochemistry was performed by growing the cells on an 
18-mm round cover glass in 6-well dishes. The cover glasses were thin-coated with 
rat tail Collagen I from GibcoTM Life Technologies Japan (Tokyo, Japan) before 
cell culture. A cell specific count was performed in a 100x magnification field. 
For frozen section, eWAT from mice collected in 4% PFA after systemic 
perfusion. The tissues were kept at room temperature for 2-3 hours. After that 
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tissues were incubated in PBS(-) for one overnight and 30% sucrose  one overnight 
in shaker at 4⁰C. At the end the tissues were placed in block by adding OCT 
compound and immediately kept block at -80⁰C for at least 24 hours to solidify it. 
Then the frozen tissues were cut into 15-20m thickness by using cryostat. EdU 
injection (20nM/mice) was injected 2hour and 96 hour before sacrifice the mice. 
After making the frozen block, immunofluoresence staining was performed by 
using EdU Alexa 647 vs anti-goat PDGFRa, 1:50 dilution (Neuromics) and 
anti-perilipin 1:50 dilution, ant-rat CD206, 1;50 dilution and anti-rabbit TGF, 1:50 
dilution followed by relevant secondary antibodies (1:250 dilution). All 
micrographs were taken with Keyence BZ-8000, Olympus BX6, or TCS SP5 Leica 
confocal microscopes (Oil 63x), and image processing was performed with the 
BZ-Analyzer software. 
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3.8 Flow cytometry analysis 
Isolation and separation of the SVF and subsequent flow cytometry were 
performed as previously described [6, 46]. Cells in the SVF of eWAT, after 
exclusion of dead cells by gating with 7AAD, live cells were selected for further 
analysis. M1-or M2-like macrophages were identified as CD45-positive/ 
F4/80-positive/ CD11c-positive/ CD206-negative or CD45 positive/ F4/80-positive/ 
CD11c-negative/ CD206-positive cells, respectively (1:50 dilution). The flow 
cytometry detection of the APs was performed similarly to a previous method [6, 
13]. First, negative selection of CD31+ (endothelial) (1:100), FITC-lineage cocktail 
cells (1:100) were selected followed by positive selection of PDGFR+ (1:50) and 
Sca-1+ cells (1:50). These experiments were performed with a FACSDiva Version 
6.1.2 automated cell analyzer (Becton Dickinson FACSCanto II) and cell sorting 
was performed by an automatic cell sorting analyzer (Becton Dickinson FACSAria 
SORP). Flow cytometry analysis for detection of BrdU intake was performed after 
the mice were injected with BrdU (10 mg/kg body weight) 3-4 times every other 
day at the same time as the DT injections. The SVF preparation and BrdU detection 
were performed using an FITC BrdU flow kit (BD PharmingenTM; BD Bioscience, 
San Diego, CA) according to the manufacturer’s instructions. Live cells were gated 
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for CD45+ and CD45- population. Then BrdU was analyzed in both fraction 
including CD45+BrdU+ and CD45-BrdU+ population. Data analyses were 
performed “offline” using FlowJo software. Unstained specimen and isotype 
negative control were used for all relevant samples to justify gating strategy. 
Fluorescence minus one (FMO) controls was used wherever needed.  
3.9 Magnetic activated cell sorting (MACS) study 
eWAT was dissociated into SVF to isolate APs as previously described [46, 
47]. The SVF were processed for magnetic sorting with anti-CD31, anti-CD45 and 
anti-Sca-1 microbeads. MicroBead Kit mouse were purchased from Miltenyi 
Biotech. First, negative selection with anti-CD31 microbeads (Cat# 130-097-418) 
and anti-CD45 microbeads (Cat# 130-052-301) was conducted. This negative 
fraction was then incubated with an anti-Sca-1 microbead kit (FITC) (Cat# 
130-092-529). The purified cells were subjected to RNA extraction and RT-PCR 
analysis of cell proliferation markers. All incubations and dilution were performed 
at 4°C for 10- 20 min according to the manufacturers’ instructions. The enriched 
(positive) fraction was then centrifuged and subjected to RNA extraction and 
RT-PCR analysis.  
27 
 
3.10 In vitro co-culture 
The bone marrow-derived macrophages (BMDM) and SVF were isolated as 
previously described [6]. BMDMs were cultured in DMEM with the addition of 
macrophage colony-stimulating factor (M-CSF) (100 ng/mL) for one week and 
were induced with IL-4 (10 ng/mL) and PGE2 (50 ng/mL) 24 hours before 
co-culture with adipose tissue-derived stem cells (ASCs). The ASCs were derived 
from an inguinal WAT (iWAT) SVF cultured with complete MesenCult proliferation 
medium that was prepared and used according to the manufacturer’s instructions 
(Stemcell Technologies, Cat# 05501). Briefly, for the adipose stem cell proliferation, 
the SVF, after the red blood cell lysis, were cultured with complete Mesencult 
proliferation medium, a combination of Mesencult MSC basal medium and MSC 
stimulatory supplement (Stemcell Technologies, Cat# 05502) in a 1:4 volume ratio, 
in a 10-mL dish with 1-2 million cells per dish. One day after seeding, the old 
medium was changed to new medium to remove the non-attached cells. The 
attached cells were grown to 60%-70% confluence before co-culturing with ASCs 
or for further re-seeding. To assess the inhibitory effect of the M2-induced BMDMs 
on ASC proliferation, a low number of BMDMs and ASCs (15,000-30,000 cells) 
were seeded together in 6-well dishes to avoid cell growth arrest because of early 
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confluence. After 1-2 days of co-culture, the cells were collected for PCR or used 
for immunohistochemistry. A TGFβRI/II inhibitor and anti-TGFβ antibodies were 
added to the medium at final concentrations of 5 ng/mL, and 0.5 μg/mL, 
respectively, on the same day the ASCs and BMDMs were seeded.  
To assess the inhibitory effect of the BMDMs on adipogenesis, the ASCs and 
BMDMs were cultured in equal numbers (100,000 cells) in 6-well dishes. ASCs 
alone and ASCs with the addition of recombinant mouse TGFβ1 (5 ng/mL, final 
concentration) were used as controls. Recombinant mouse TGFβ1 and a TGFβRI/II 
inhibitor were added on the first day of co-culture in Mesencult complete MSC 
stimulatory medium. After two days of confluence, the medium was changed to 
Mesencult complete adipogenic stimulatory medium, which was a combination of 
Mesencult MSC basal medium and Mesencult adipogenic stimulatory supplement 
with a 1:4 volume ratio. Every 4-5 days, the medium was changed with new 
complete stimulatory medium with the addition of new reagents (Recombinant 
Mouse TGFβ1, TGFβRI/II inhibitor, and M-CSF). After 12 days of adipogenesis 
induction, the cells were collected for PCR and Oil Red O staining (Thermo 
Scientific, SC 00011) for adipocyte visualization. 
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3.11 Glucose tolerance test and insulin tolerance test 
In the intraperitoneal glucose tolerance test (IP-GTT), 6h fasted DT-treated 
CD206DTR and littermate was injected with glucose (1mg/g BW) intraperitoneally. 
In the intraperitoneal insulin tolerance test (IP-ITT), 2 h fasted mice were injected 
intraperitoneally with human insulin 0.8 units/kg BW for NC-fed and 1.2 units/kg 
BW for HFD-fed mice. Blood samples were then collected 0,15, 30, 45, 60, 90 and 
120 min from the tail vein. The blood glucose levels were measured using the STAT 
STRIP Express 900 (Nova Biomedical, Waltham MA). The serum insulin levels 
were determined using the Mouse Insulin ELISA KIT (ARKIN-031, Shibayagi, 
Shibukawa, Japan). 
3.12 Hyperinsulinemic-euglycemic clamp study 
Clamp studies were performed on 16 weeks HFD-fed DT-treated CD206DTR 
and WT littermate under conscious and unstressed condition after 6 hours fasting as 
described previously [48, 49]. A primed-continuous infusion of insulin (Humulin R; 
Lilly) was given 10.0 milli units/kg/min for HFD-fed mice, and the blood glucose 
concentration, monitored every 5 min, was maintained at ~120 mg/dl by 
administration of glucose (50% glucose enriched to ~20% with 50%  D2-glucose 
(Sigma) (4:1) ratio for 120 min. Blood sample collected at 0, 90, 105, and 120 min 
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for determination of the rate of glucose disappearance (Rd), and hepatic glucose 
production (HGP) was calculated as the difference between Rd and exogenous 
glucose infusion rates (GIR) [48]. 
3.13 Statistical analysis 
Statistical analyses were performed using unpaired Student’s t-tests or 
ANOVAs with the post Tukey–Kramer test and Bonferroni correction. Differences 
were considered statistically significant at *P < 0.05, ** P < 0.01. The results are 
presented as the means ± SEM. 
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3.14 Materials 
Diphtheria toxin (Sigma, cat# D0564,) and collagenase (Sigma, cat# C6885) 
were purchased from Sigma-Aldrich (St. Louis, MO). Anti-human diphtheria toxin 
receptor (anti-HB-EGF) was obtained from Cosmo Bio, cat# 71-503 (Tokyo, Japan), 
purified mouse anti -catenin (Cat# 610154) from BD Bioscience, anti-rabbit Akt 
(Cat# 9272S) and anti-rabbit p-Akt (S473) (Cat# 9271S) were purchased from Cell 
Signaling for western blot analysis. The horseradish peroxidase linked anti-mouse, 
cat# NA931V and anti-rabbit, cat# NA934V secondary antibodies were obtained 
from Amersham Bioscience (Buckinghamshire, UK). The ECLTM western blot 
detection reagent was obtained from GE Healthcare, cat# RPN2232 
(Buckinghamshire, UK). Tamoxifen was purchased from Sigma, cat# T5648 and 
bromodeoxyuridine (BrdU) was purchased from BD Biosciences, cat# 550891. 
D-Glucose-6,6-d2 was purchased from the Santa Cruz Biotechnology, cat# 
sc-257287A.  
The PCR primers that were used with the TaqMan method were purchased 
from Applied Biosystems (Foster City, CA), and those used with the SYBR Green 
method were purchased from InvitrogenTM Life Technologies, Japan (Tokyo, 
Japan).   
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3.14.1 Table; List of SYBR Green primers 
Ki-67 
Forward:CGCCAACCAAGAGGAAGTCT                             
Reverse: GGGGCCGTTCCTTGATGATT 
p15 
Forward: CCACCCTTACCAGACCTGTG 
Reverse: AGGCGTCACACACATCCAG 
p16 
Forward: GAACTCTTTCGGTCGTACCC 
Reverse: CGAATCTGCACCGTAGTTGA 
p21 
Forward: GACATCTCAGGGCCGAAAAC 
Reverse: CGGCGCTTGGAGTGATAGAA 
p27 
Forward: AGGAGAGCCAGGATGTCAGC 
Reverse: CAGAGTTTGCCTGAGACCCAA  
p57 
Forward: GGAGCAGGACGAGAATCAAG 
Reverse: GAAGAAGTCGTTCGCATTGG 
TGFβ1 
Forward: AAGTTGGCATGGTAGCCCTT 
Reverse: GCCCTGGATACCAACTATTGC 
TGFβ2 
Forward: AGGAGGTTTATAAAATCGACATGC  
Reverse: TAGAAAGTGGGCGGGATG 
TGFβ3 Forward: CCCTGGACACCAATTACTGC  
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Reverse: TCAATATAAAGGGGGCGTACA 
C/EBPα 
Forward: TGGACAAGAACAGCAACGAG 
Reverse: TCACTGGTCAACTCCAGCAC 
CD24 
Forward: TGCTCCTACCCACGCAGATT 
Reverse: GCGTTACTTGGATTTGGGGAAGCA 
Pref-1 
Forward: AACCATGGCAGTGCATCTG 
Reverse: GCATTCGTACTGGCCTTTCT 
Zbtb46 
Forward:AGAGAGCACATGAAGCGACA                                                       
Reverse: CTGGCTGCAGACATGAACAC 
Sca-1 
Forward:TCTGAGGATGGACACTTCTC                                                       
Reverse: CTCAGGCTGAACAGAAGCAC  
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For the flow cytometry analysis, hamster CD11c conjugated with PE (Cat# 553802), 
PE rat anti-mouse Siglec F (Cat# 562068), purified rat anti-mouse CD16/CD32 
(Cat# 553141), 7-amino-actinomycin D [7AAD] (Cat# 559925), PE ArHam IgG1 
λ2 isotype control (Cat# 553954), FITC BrdU flow kit (Cat# 559619), APC rat 
anti-mouse TER-119/erythroid cell antibody (Cat# 557909) antibodies were 
obtained from BD Biosciences. PE hamster rat polyclonal isotype control (Cat# 
ab32662-100) was purchased from Abcam. The rat anti-mouse CD206 conjugated 
Alexa Fluor 647 antibody (Cat# MCA2235A647) and the rat IgG2a Alexa Fluor 
647 isotype antibodies (Cat# 1212A647) were obtained from AbD Serotec (Oxford, 
UK). The APC anti-mouse CD206 (MMR) antibody (Cat# 141707) and the APC rat 
IgG2a,  isotype control antibody (Cat# 400511), FITC anti-mouse Ly6G/Ly-6C 
(Gr-1) (Cat# 108406), FITC conjugate rat IgG2a isotype control, FITC anti-mouse 
CD3/Gr-1/CD11b/CD45R(B220)/Ter-119 (FITC lineage cocktail) (Cat# 78022), 
FITC Arm Hamster IgG/rat IgG2b/rab IgG2a isotype control (Cat# 78023), APC 
anti-mouse CD140a (Cat# 135908), PE anti-mouse CD140a (Cat# 135905), PE rat 
IgG1,  isotype control (Cat# 553925) and APC/Cy7 anti-mouse Ly-6A/E (Sca-1) 
(Cat# 108125), the APC/Cy7 rat IgG2a,   isotype control (Cat#  400523), rat 
anti-mouse F4/80 conjugated APC/Cy7 (Cat# 123117) antibodies were purchased 
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from BioLegend. Anti-mouse CD45 PE-Cy7 (Cat# 25-0451), PE-Cy7 rat IgG2a,  
isotype control (Cat# 25-4321-81) and anti-mouse CD31 PE-Cy7 (Cat# 25-0311), 
APC-eFluor 780 anti-mouse CD11b (47-0112-82) antibodies were purchased from 
eBioscience. 
For the immunohistochemistry experiments, the anti-human diphtheria toxin 
receptor (anti-HB-EGF) antibody was obtained from Antibodies –online (Cat# 
ABIN701052); the biotin anti-BrdU (Cat# 339809) and FITC anti-mouse F4/80 
(Cat# 123107), APC/Cy7 anti-mouse F4/80 (Cat# 123107),; the anti-TGFβ1 (Cat# 
sc-146), monoclonal anti-CD206 (Cat# sc-58987), and anti-rabbit perilipin (Cat# 
sc-67164) antibodies were obtained from Santa Cruz Biotechnology (Dallas, Texas); 
the anti-rabbit Phospho Smad2/3 (Cat# 8828) primary antibody, anti-rabbit p27 
(Cat# 3698) primary antibody, goat anti-rabbit IgG (H+L), Alexa Fluor 555 
conjugate (Cat# 4413), anti-rabbit Alexa Fluor 488 (Cat# 4413), and goat anti-rat 
IgG (H+L) Alexa Fluor 488 conjugate (Cat# 4413) secondary antibodies were 
obtained from Cell Signaling Technology (Denvers, MA); and goat anti-guinea pig 
IgG (H+L) Alexa Fluor 488 conjugate (Cat# A11073), donkey anti-rabbit IgG 
(H+L) Alexa Fluor 488 conjugate (Cat# A21206) secondary antibodies and 
Click-iT® EdU Alexa Fluor 647 Imaging Kit (Cat# 10340) were obtained from Life 
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technologies. Anti-rabbit Ki-67 antibody was obtained from Abcam (Cat# ab15580) 
(Cambridge, UK). The anti-goat PDGFR antibody (Cat# GT15150) was purchased 
from Neuromics. Anti-GFP (Guinea pig) (Cat# GFP-GP-AF1180) were purchased 
from Frontier Institute Co., ltd. Cell mask green plasma membrane stains were 
purchased from molecular probes by Life Technologies, cat# C37608.  
For the in vitro experiments, the Dulbecco’s modified Eagle’s medium was 
purchased from GibcoTM Life Technologies, Japan (Tokyo, Japan); the MesenCult 
MSC basal medium (Mouse), MSC proliferation supplement (mouse), and the 
adipogenic stimulatory supplement (mouse) were purchased from STEMCELL 
(Vancouver, Canada); the recombinant Interleukin-4 (IL-4) (Cat# 214-14) was 
purchased from Peprotech (Rocky Hill, NJ); the prostaglandin E2 (PGE2) (Cat# 
363-244-6) was purchased from Caymen Chemical (Ann Arbor, Michigan); the 
recombinant mouse TGFβ1 (Cat# 7666-MB-005), macrophage colony-stimulating 
factor (M-CSF) (Cat# 416-ML-050), and the monoclonal mouse anti-TGFβ1, 2, and 
3 (Cat# MAB1835) were purchased from R&D Systems (Minneapolis, MN); the 
TGFβRI/II inhibitor (LY2109761) (Cat# CS-0571) was purchased from Chem 
Scene (Monmouth Junction, NJ). 
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4.0 Results 
4.1 Effect of depletion of CD206+ M2-like macrophages in adipose tissue and other 
tissues 
We administered DT injections three times every other day and found that 
injection of DT with dose 3ng/gBW (Figure 4a) specifically reduces the number of 
CD206+ M2-like macrophages without affecting body weight (Figure 4b), the weight of 
eWAT or iWAT (Figure 4c) or even food intake (Figure 4d). DT administration did not 
affect the number of M1-like macrophages and expression levels of M1-like markers in 
the eWAT (Figure 4e and 4f), although minor alterations in the expression of natural 
killer cells and eosinophils were observed in the eWAT of CD206+ M2-like 
macrophages-reduced mice (Figure 4g). These data suggested that CD206+ M2-like 
macrophages are specifically depleted.
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Figure 4.  Effect of depletion of CD206
+
 M2-like macrophages on 
overall health status and in adipose tissue  
(a) A schematic diagram of the DT injection method for metabolic analysis of 
CD206DTR mice. (b) Body weights and before and after DT injections, and (c) weight 
of adipose tissue and (d) food intake after DT injection period (n=4–6 mice per group). 
(e) Representative flow cytometry analysis of CD11c and CD206 expression in F4/80+ 
SVF cells of eWAT from WT and CD206DTR mice (left panel). Percentages of F4/80+ 
cells, M1 and M2 macrophages were calculated (right panel) (n=5–6 mice per group). 
(f) Relative mRNA expression of M1/M2 macrophage markers in the eWAT after DT 
treatment (n=5–6 mice per group). (g) Relative mRNA expression of various 
hematopoietic cell marker genes in the eWAT. The data are shown as the means ± SEM.  
*P < 0.05, **P < 0.01 compared with littermate by Student's t-test.  
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Additionally, we found that the depletion of CD206+ M2-like macrophages do 
not alter fibrosis of WAT (Figure 5a). The expression of CD206 and other M2-like 
macrophages were also downregulated in the iWAT of DT-treated CD206DTR mice 
(Figure 5b). Decline of CD206+ M2-like macrophages were also observed in bone 
marrow (BM), the liver and skeletal muscle of CD206+ M2-like macrophages-reduced 
mice (Figure 5c-e). Flow cytometric analysis of the peritoneal cavity macrophages 
revealed that CD206+ M2-like macrophages were also depleted (Figure 6a). In addition, 
gene expression and flow cytometric analysis of BM shows that the number of 
eosinophils, natural killers cells and granulocytes was unaffected (Figure 6b-d). Thus, 
the current protocol provides an effective approach for systemic reduction of CD206+ 
M2-like macrophages without affecting the numbers of other lineage cells, body weight, 
adiposity, or food intake. 
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Figure 5.  Effect of depletion of CD206
+
 M2-like macrophages fibrosis 
of WAT and other tissues  
(a) Representative images of Azan-stained sections of eWAT from DT-treated WT and 
CD206DTR mice. Scale bars, 500 μm. Fibrotic area (blue) was analyzed by ImageJ 
software. The data are shown as the means ± SEM.  *P < 0.05 compared with 
littermate by Student's t-test. Data are representative of at least two independent 
experiments. (b) Relative mRNA expression of M1-like and M2-like macrophages 
markers in the iWAT. (c-e) Relative mRNA expression of M1/M2 macrophage markers 
in the BM and liver and skeletal muscle after DT treatment (n=5-6 mice per group). The 
data are shown as the means ± SEM.  *P < 0.05 compared with littermate by Student's 
t-test.  
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Figure 6.  Effect of depletion of CD206
+
 M2-like macrophages on 
peritoneal macrophages and bone marrow (BM)  
(a) Representative flow cytometry analysis of peritoneal cavity macrophages from WT 
mice (upper panel) and M1- and M2-like macrophage quantification in WT and 
CD206DTR mice (lower panel). After the exclusion of doublets and debris, dead cells 
were excluded by 7AAD staining. Leukocytes in peritoneal cavity were identified by 
CD45 staining. CD45+ cells were further gated for F4/80-positive macrophages to 
identify M1 and M2 macrophages. Isotype control antibody for the anti-CD11c and 
anti-CD206 were used as a negative control. (b) Relative mRNA expression of 
granulocytes, natural killer cells and eosinophils in BM from DT-treated WT and 
CD206DTR mice. The data are shown as the means ± SEM.  *P < 0.05 compared with 
littermate by Student's t-test. (c) Representative flow cytometry analysis of eosinophils 
(SiglecF+) in BM from WT and CD206DTR mice (left panel) and quantification of 
these cells (right panel). Live (7AAD-) cells were gated for CD45+ cells and then 
SiglecF fraction was analyzed in CD45+ cells. Isotype control antibody was used as a 
negative control. The data are shown as the means ± SEM.  *P < 0.05 compared with 
littermate by Student's t-test. (d) Representative flow cytometry analysis of CD11b and 
Gr-1 expression in BM (left panel) and quantification of CD11hi Gr-1hi and CD11bint 
Gr-1int cells (right panel). Live (7AAD-) cells were gated for CD45+ cells and then 
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CD11b and Gr-1 expression was analyzed in CD45+ cells. Isotype control antibody for 
the relative antibodies was used as a negative control. The data are shown as the means 
± SEM.  *P < 0.05 compared with littermate by Student's t-test.  
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4.2 Depletion of CD206+ M2-like macrophages triggered the proliferation of 
nonhematopoietic stromal vascular fractions (SVF) cells in the eWAT 
Next, we evaluated the physiology of the adipose tissues by examining the size 
and number of adipocytes. In CD206+ M2-like macrophages-reduced mice, the size of 
adipocytes was significantly reduced (Figure 7a), while the numbers of adipocytes 
(Figure 7b) and SVF populations (Figure 7c) were increased in eWAT. Flow cytometric 
analysis revealed that BrdU-uptake was increased in the CD45- SVF cells of CD206+ 
M2-like macrophages-reduced mice (Figure 7d), suggesting that the depletion of 
CD206+ M2-like macrophages resulted in the proliferation of CD45- cells. In agreement 
with this, expression of cell cycle indicators, such as cyclins and Ki-67, was also 
increased in the eWAT of CD206+ M2-like macrophages-reduced mice (Figure 7e). We 
also found an increased number of Ki-67- and BrdU-positive cells in CD206+ M2-like 
macrophages-reduced mice (Figure 7f). Taken together, these data suggested CD206+ 
M2-like macrophages depletion triggered the proliferation of CD45- SVF. 
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Figure 7. Depletion of CD206
+
 M2-like macrophages induces 
generation of smaller adipocytes  
(a) Representative sections of eWAT from WT and CD206DTR were stained with 
hematoxylin and eosin (HE) (left panel) and adipocyte size (right panel); Scale bar, 100 
μm. (b) Cell count measurements in the eWAT. (c) Cell count of SVF obtained from 
eWAT of DT-treated WT and CD206DTR mice (n=4-5 mice per group). (d) 
Representative flow cytometry analysis of BrdU+ cells in CD45- SVF from WT and 
CD206DTR mice (left panel). Percentages of CD45+/BrdU+ and CD45-/BrdU+ fractions 
in SVF from WT and CD206DTR mice were calculated (right panel) (n=4-5 mice per 
group). (e) Relative mRNA expression of cell cycle and proliferating marker genes in 
the eWAT (n=4-7 per group). (f) Representative paraffin eWAT sections of Ki-67 
immunostaining counterstained with eosin (bluish) (upper panel), and BrdU uptake 
(lower panel). Scale bar, 100 μm. Quantification (right panel; n=3-6 per group). The 
data are shown as the means ± SEM.  *P < 0.05, **P < 0.01, ns= non-significant 
compared with littermate by Student's t-test.   
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4.3 CD206+ M2-like macrophages regulate adipocyte progenitor’s proliferation 
We examined which type of CD45- cells in the eWAT were proliferating after 
CD206+ M2-like macrophages depletion. Since macrophages are reportedly involved in 
the regulation of progenitor activity or stem cell niche activity [3, 14, 50-52], we 
investigated the possible involvement of CD206+ M2-like macrophages in the control of 
APs proliferation. As shown in Figure 8a, expression of a series of AP markers 
including PDGFRa, CD24, Sca-1 and Pref-1 [47, 53-55], and mesenchymal stem cell 
(MSC) markers including CD105 and CD90 [11, 56] were up-regulated in eWAT of the 
CD206+ M2-like macrophages-reduced mice. These data indicated that proliferating 
cells might be APs. To directly assess the proliferation state of APs, the 
CD45-CD31-Sca-1+ non-endothelial fraction was purified using magnetic activated cell 
sorting (MACS) (Figure 8b). Sca-1+ fractions showed even larger increments in the 
expression of cell cycling indicator genes under CD206+ M2-like macrophages 
reduction than did Sca-1- fractions (Figure 8c), indicating that the proliferation state of 
APs was indeed activated in CD206+ M2-like macrophages-reduced mice.  
In agreement with this, flow cytometry analysis revealed that the number of 
Sca-1/PDGFR double positive populations [54, 57] was increased (Figure 8d) and cell 
cycle gene expression levels in APs fraction (Figure 8e) were up-regulated, indicating 
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that depletion of CD206+ M2-like macrophages enhances the proliferation of APs. 
Taken together, CD206+ M2-like macrophages negatively regulates APs proliferation in 
the eWAT.
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Figure 8. Effects of CD206
+
 M2-like macrophages depletion on 
adipocyte progenitor’s proliferation  
(a) Relative mRNA expression of mesenchymal stem cell (MSC) and APs marker 
genes in the eWAT (n=4–6 mice per group). (b) A schematic diagram showing the 
MACS processing. First, the eWAT was fractionated into adipocytes and SVF. The SVF 
were then processed MACS bead, as described in the methodology section. (c) Relative 
mRNA expression of MACS purified Sca-1 positive fraction (n=3 mice per group). (d) 
Representative flow cytometry analysis of Sca-1/PDGFR double positive cells in the 
SVF of eWAT from DT-treated WT and CD206DTR mice (left panel). Percentage of 
Sca-1/PDGFR double positive fraction in the SVF of these mice was calculated (right 
panel; n=3–5 per group). (e) Relative mRNA expression of flow cytometry sorted 
Sca-1/PDGFR double positive fraction in the eWAT (n=3–4 mice per group). The data 
are shown as the means ± SEM.  *P < 0.05, **P < 0.01 compared with littermate by 
Student's t-test. 
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4.4 Fate of adipocyte progenitor’s proliferation 
To confirm the identity and the fate of proliferating cells, To confirm the 
identity and the fate of proliferating cells, EdU was injected and cellular uptake of 
proliferating cells were chased. First, we examined eWAT after 2 hours from EdU 
injection and found that some PDGFR(+) cells were labeled with EdU, indicating that 
these cells are under proliferation. We also determined an increment in the number of 
EdU labeled nuclei in DT-treated CD206DTR mice (Figure 9a). After 96 hours from 
EdU injection, EdU-labeled nuclei (red) had been differentiated into multilocular 
perilipin(+) adipocytes (Figure 9b). Thus, proliferating APs in CD206+ M2-like 
macrophages-reduced mice were indeed differentiated into mature perilipin-positive 
adipocytes. When stained by CellMask™ Green Plasma Membrane Stain, we found that 
some EdU+ nuclei were not separated from the lipid droplets by a plasma membrane 
(Figure 9c), a characteristic of terminally maturated adipocytes with high lipid-storing 
capacities [58]. Thus, CD206+ M2-like macrophages reduction promotes the 
proliferation of APs, which are subsequently differentiated into mature adipocytes. 
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Figure 9. Depletion of CD206
+
 M2-like macrophages enhanced EdU 
uptake  
(a) Representative confocal images of eWAT frozen sections triple-stained for 
PDGFR, EdU and DAPI 2 hours after EdU injection. The nuclei were counterstained 
with DAPI (blue). Scale bar, 25 m. (b) Representative images of frozen eWAT 
sections triple-stained for perilipin, EdU and DAPI 96 hours after EdU injection. The 
nuclei were counterstained with DAPI (blue). The images were taken with Leica 
TCS-SP5 (Oil 63x). Scale bar, 25 m. (c) High resolution confocal imaging of 
CellMask™ Green Plasma Membrane Staining of frozen eWAT sections. The plasma 
membrane was stained with Cell Mask Green (green), proliferating cells were stained 
with EdU (red) and the nuclei were stained with DAPI (blue). White arrow shows 
adipocytes and red arrow shows non-adipocytes. The images were taken with a Leica 
TCS-SP5 (Oil 63x). Scale bar, 25 m. (White arrows= adipocyte, Red arrow= Non 
-adipocytes).  The data are shown as the means ± SEM.  *P < 0.05, **P < 0.01 
compared with littermate by Student's t-test.  
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4.5 Mechanism involved in M2-induced inhibition of adipocyte progenitor’s 
proliferation 
What are the mechanisms of CD206+ M2-like macrophages to inhibit the 
proliferation and differentiation of adipocyte progenitors? M2-like macrophages express 
fairly large amounts of TGFβ1 [59-61] and TGFβ1 is reportedly involved in inhibiting 
proliferation/differentiation of various cell types including preadipocytes, melanocyte- 
and hematopoietic-stem cells [38, 39, 44]. It is known that TGFβ1 inhibits the 
differentiation of 3T3-L1 preadipocytes [44]. Since M2-like macrophages reportedly 
express TGFβ1 at a high level [59], we hypothesized that CD206+ M2-like macrophages 
would provide a niche for APs via TGFβ signaling. Enhanced TGF signaling is also 
reportedly associated with obesity [40-43, 62]. We therefore examined the possible 
involvement of TGF signaling in the up-regulated APs proliferation in CD206+ 
M2-like macrophages-reduced mice. Among the genes involved in TGF signaling, 
TGF1 was abundantly expressed in CD206+ M2-like macrophages (Figure 10a). 
Confocal imaging studies demonstrated co-localization of CD206+ M2-like 
macrophages with TGFβ immunostaining in eWAT (Figure 10b). Furthermore, we also 
found that the number of cells that co-express CD206 and TGF1 was reduced in 
CD206+ M2-like macrophages-depleted mice (Figure 10c). CD206+ M2-like 
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macrophages were located in close proximity to PDGFR+ APs, as shown in 
PDGFR-CreERT2-eGFP (PRa) mice (Figure 10d), consistent with a previous report [3]. 
Co-localization of APs with p27Kip1, a downstream factor of TGFβ signaling for cell 
growth inhibition, was also confirmed in PRa mice (Figure 10e). Expression of other 
TGFβ signaling downstream factors including p21, p15, p16, p27 and p57 were 
down-regulated in eWAT in CD206+ M2-like macrophages-reduced animals (Figure 
10f). In addition, immunohistochemical analysis show that TGF1, phospho-smad2/3 
(P-Smad2/3) and p27Kip1 protein expression was reduced by depletion of CD206+ 
M2-like macrophages (Figure 10g), suggesting that CD206+ M2-like macrophages 
suppress APs proliferation via the TGFβ signaling pathway.  
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Figure 10. TGFβ signaling is reduced after CD206+ M2-like macrophages depletion 
(a) Relative mRNA expression of CD206, TGFβ1, TGFβRI and TGFβRII, in the SVF, 
macrophages (CD206+), and APs (Sca-1/PDFRa double positive) purified from eWAT 
of WT mice by using flow cytometry cell-sorting (FACS) analysis (n=4-5 per group). 
(b) High resolution confocal imaging of frozen eWAT sections from WT mice. Scale 
bar, 25 m. (c) Representative images of eWAT paraffin sections stained for CD206 
and TGF (Scale bar, 200 m) in DT-treated CD206DTR and WT littemate. (d,e) 
High resolution confocal imaging of frozen eWAT sections from PRa mice stained for 
CD206 vs GFP and GFP vs p27. The images were taken with a Leica TCS-SP5 (Oil 
63x). Scale bar, 25 m. (f) Relative expression of TGFβ signaling genes from eWAT. 
(g) Representative immunohistochemical staining of the eWAT paraffin section for 
TGFβ1, phospho-smad2/3 (P-Smad2/3), and p27. Scale bar 100m. Quantification 
(right panel) (n=3-4 per group). The data are shown as the means ± SEM.  *P < 0.05, 
**P < 0.01 compared with littermate by Student's t-test.  
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4.6 Generation of CD206-CreERT2/TGFflox/flox mice 
To validate this hypothesis, we generated a genetically engineered mouse in 
which TGFβ1 expression was specifically depleted in CD206+ M2-like macrophages 
(CD206-CreERT2/TGFflox/flox mice) (Figure 11a). Administration of tamoxifen 
significantly reduced TGF expression by 20–30% in CD206+ M2-like macrophages 
in the CD206-CreERT2/TGFflox/flox mice (Figure 11b), showing that 
CD206-CreERT2/TGFflox/flox mice were successfully created.  
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Figure 11. Creation of CD206-CreERT2/TGFflox/flox mice 
(a) A schematic diagram showing creation of CD206-CreERT2/TGFflox/flox mice. (b) 
Relative mRNA expression of FACS-sorted CD206+ cells from the eWAT of tamoxifen 
treated CD206-CreERT2/TGFflox/flox mice compared with control TGFflox/flox mice 
(n=3). The data are shown as the means ± SEM.  *P < 0.05 compared with littermate 
by Student's t-test.   
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4.7 Deletion of TGF1 within CD206+ M2-like macrophages increased 
adipocyte progenitors in the adipose tissue  
 Then, we examined gene expression analysis of whole adipose tissue and SVF 
from tamoxifen treated CD206-CreERT2/TGFflox/flox mice compared with their 
littermate. Gene expression analysis shows that the expression of cell cycle-associated 
genes and APs marker genes (Figure 12a) were upregulated in TGF1 deleted mice. 
Further we performed flow cytometric analysis to assess APs in these mice. Flow 
cytometry analysis shows that the number of Sca-1/PDGFR double positive 
populations in eWAT was enhanced in these mice (Figure 12b). Further, 
immunostaining analysis shows that fibrosis of eWAT was decreased in tamoxifen 
treated CD206-CreERT2/TGFflox/flox mice compared to tamoxifen treated TGFflox/flox 
control mice (Figure 12c). To ascertain involvement of the TGFβ signaling pathway in 
the suppression of APs proliferation, the eWAT of WT mice was directly injected with 
either an anti-TGFβ1,2,3 neutralizing monoclonal antibody (1D11) or PBS(-). As 
expected, this single injection of 1D11 augmented cell cycle-related gene expression 
and reduced expression of genes located downstream of TGFβ signaling (Figure 12d). 
These data confirmed that the down-regulation of TGFβ signaling in the eWAT 
triggered the APs proliferation.  
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Figure 12. Effect of deletion of TGF1 from CD206+ M2-like macrophages in 
adipose tissue and effect of direct injection of anti-TGF1,2,3 on cell proliferation 
(a) Relative mRNA expression of eWAT and SVF from the 
CD206-CreERT2/TGFflox/flox mice compared with control TGFflox/flox mice (n=4-5).  
The data are shown as the means ± SEM.  *P < 0.05 compared with littermate by 
Student's t-test.  
(b) Representative flow cytometry analysis of Sca-1/PDGFR double positive 
population in the SVF of eWAT from CD206-CreERT2/TGFflox/flox and TGFflox/flox 
control mice (left panel). Percentage of Lineage (-)Sca-1/PDGFR double positive 
fraction was calculated (right panel; n=4-5 per group). This experiment was performed 
with a FACSDiva Version 6.1.2 automated cell analyzer (Becton Dickinson FACSCanto 
II) and cell sorting was performed by an automatic cell sorting analyzer (Becton 
Dickinson FACSAria SORP).  
(c) Representative images of Azan-stained sections of eWAT from mice used tamoxifen 
treated CD206-CreERT2/TGFflox/flox mice compared to tamoxifen treated TGF1flox/flox 
control mice. Scale bars, 500 μm. Fibrotic area (blue) was analyzed by ImageJ software. 
The data are shown as the means ± SEM.  *P < 0.05 compared with littermate by 
Student's t-test. Data are representative of at least two independent experiments.  
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(d) Relative mRNA expression of cell cycle and TGFβ signaling genes from eWAT 
samples collected after direct injection of a single dose of TGFβ 1,2,3 neutralizing 
antibody (1D11) into the eWAT (n=3). The data are shown as the means ± SEM.  *P < 
0.05, **P < 0.01 compared with littermate by Student's t-test.  
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4.8 In vitro co-culture of adipose tissue-derived stem cells (ASC) and 
bone marrow-derived macrophages (BMDM) 
 Macrophages are known to secrete TGFβ [59-61]. In many reports, TGFβ1 has 
been implicated in the inhibition of the proliferation and differentiation of various cell 
types, including adipocytes [38, 39, 44]. Several pieces of studies revealed that both 
human and mouse obese adipose tissue showed higher level of expression of TGFβ1 
[41-43]. TGF-β1 secreted from white APs is involved in fibrosis by induction of 
myeloid cells [63]. Recent report shows that TGF was secreted from adipocyte in the 
WAT and contribute to regulate adiposity and insulin sensitivity [40]. TGF reportedly 
inhibited adipocyte differentiation [64]. Its higher expression or circulating levels are 
associated with obesity. Since M2-like macrophages reportedly express TGFβ1 at a high 
level, we hypothesized that CD206+ M2-like macrophages would provide a niche for 
APs via TGFβ signaling. To examine whether M2-like macrophage-derived TGFβ 
signaling had an inhibitory effect on APs proliferation and differentiation into 
adipocytes, we performed inhibitor analysis in vitro. ASCs harvested from the iWAT of 
WT mice were co-cultured with CD206+TGF1+ M2-like macrophages, which were 
produced from bone BMDM by treating with IL-4 and PGE2. We found, when 
co-cultured ASC with BMDM derived M2-like macrophages; M2-like macrophages 
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inhibited the differentiation of ASC. We screened several compounds that release the 
inhibition of differentiation of ASC or preadipocytes by M2-like macrophages. We 
found that a TGFRI/II inhibitor released the inhibition by M2-like macrophage, 
consistently with the reported finding that TGF1 inhibit the differentiation of ASC. 
The presence of LY2109761 (a TGFRI/II inhibitor) abrogated the inhibitory effect of 
BMDM on adipogenesis of ASC (Figure 13a, b) although LY2109761 per se, or 
anti-TGFβ1,2,3 enhanced PDGFR+ cell proliferation (Figure 14a,b). We found that 
BMDM-induced-inhibition of ASC adipogenesis in this co-culture system was negated 
when the LY2109761 was added. Thus, CD206/TGF signaling regulates the APs 
proliferation and subsequent adipogenesis. 
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Figure 13. In vitro coculture of BMDM and ASC 
(a) Oil red O staining of ASC and ASC:BMDM co-culture after adipogenesis 
stimulation for 12 days. Addition of TGFβ1 (right upper panel) and BMDM to ASC 
(left lower panel) inhibited adipogenesis. Scale bar, 200 m. (b) Relative mRNA 
expression levels of late adipogenesis marker genes. The data were calculated from 
experiments of 3-6 dishes per group. The data are shown as the means ± SEM.  *P < 
0.05, **P < 0.01 compared with control by ANOVA. 
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Figure 14. Reversal of BMDM-induced inhibition of cell proliferation 
(a) Quantification of PDGFRα and CD206 in in vitro co-cultures of ASC and BMDM 
after the addition of a TGFβRI/II inhibitor (LY2109761) and anti- TGFβ1,2,3 antibody  
to the medium for 48 hours. The PDGFRα and CD206+ M2-like macrophages were both 
counted as the percentages of DAPI-positive cells. (b) Relative mRNA expression 
levels of cell proliferation-related genes and PDGFRα. The data were calculated from 
experiments of 3-6 dishes per group. The data are shown as the means ± SEM. *P < 
0.05, **P < 0.01 compared with control by ANOVA.   
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4.9 CD206+ M2-like macrophages depletion improves glucose metabolism in lean 
mice 
We have previously showed that the majority of macrophages were M2-type in 
non-obese states, whereas the majority of macrophages were M1-type in obese states 
[13]. Since M2-like macrophages are considered to be metabolically ‘favorable’ ATMs 
[17, 65] compared with M1 pro-inflammatory macrophages, it was expected that 
decline of CD206 M2-like macrophages might impair glucose metabolism despite 
enhanced APs proliferation. Surprisingly, glucose tolerance and insulin sensitivity were 
improved in CD206+ M2-like macrophages-reduced mice (Figure 15a-c). This 
unexpected finding was indeed a specific outcome of CD206+ M2-like macrophages 
reduction, since a glucose tolerance test without DT administration did not reveal any 
difference between WT and CD206DTR mice (Figure 15d). In CD206+ M2-like 
macrophages-reduced mice, the levels of Akt phosphorylation were up-regulated in 
eWAT, liver and skeletal muscle after insulin injection (Figure 15e-g). Moreover, 
expression levels of the genes associated with metabolically favorable states were also 
up-regulated in eWAT and skeletal muscle, while gluconeogenesis-related gene 
expressions were down-regulated in the liver (Figure 16a-c). In addition, gene 
expression analysis revealed that expressions of markers for smaller adipocytes were 
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consistently up-regulated in the eWAT, reflecting the increment in smaller adipocytes 
(Figure 16a). Expression levels of adipogenesis-related transcription factors including 
C/EBP-δ and C/EBP-α were also markedly up-regulated in the eWAT (Figure 16a). 
Thus, decline in CD206/TGFsignaling promoted adipogenesis to provide an 
increment in smaller adipocytes in the WAT, thereby improving insulin sensitivity. 
Similar effect was also observed in genetically engineered 
CD206-CreERT2/TGFflox/flox mice, the number of smaller adipocytes was also 
increased after tamoxifen treatment (Figure 16d), supporting our hypothesis about the 
involvement of CD206/TGFsignaling in glucose metabolism. Thus, decline of 
CD206/TGFsignaling improves glucose metabolism in lean mice.  
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Figure 15. CD206+ M2-like macrophages depletion promotes insulin sensitivity in 
lean mice 
(a, b) Glucose and insulin concentrations in an intra-peritoneal glucose tolerance test 
(IP-GTT), and (c) the glucose concentrations in an intra-peritoneal insulin tolerance test 
(IP-ITT) in NC-fed mice after DT treatment (n=4–6 per group). (d) The glucose 
concentrations in an intra-peritoneal glucose tolerance test (IP-GTT) in NC-fed 
CD206DTR and WT mice without DT treatment (n=3-5 per group). The data are shown 
as the means ± SEM.  *P < 0.05, **P < 0.01 (Student's t-test). (e-g) Western blot 
analysis of Akt phosphorylation in the eWAT, liver and skeletal muscle of DT-treated 
CD206DTR and WT littermates. (MW= Molecular weight).  
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Figure 16. CD206+ M2-like macrophages depletion promotes glucose metabolism 
(a) Relative mRNA expression of mitochondrial, smaller adipocytes and adipogenesis 
marker genes in the eWAT (n=3–5 per group). (b) Relative mRNA expression of 
gluconeogenesis and fatty acid oxidation genes in the liver and (c) skeletal muscle 
(n=3–5). The data are shown as the means ± SEM.  *P < 0.05, **P < 0.01 compared 
with littermate by Student's t-test. (d) Representative HE-immunohistochemistry 
micrographs (left panel) and adipocyte size and cell count measurements (right panel) in 
the eWAT of CD206-CreERT2/TGFflox/flox compared with TGFflox/flox control mice are 
shown. (200x magnifications); Red scale: 200 μm. (n=3 per group). The data are shown 
as the means ± SEM.  *P < 0.05 compared with littermate by Student's t-test.  
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4.10 CD206+ M2-like macrophages depletion improve glucose metabolism in obese 
mice 
Next, we examined the impact of CD206+ M2-like macrophages reduction on 
glucose metabolism under HFD-fed conditions. WT and CD206DTR mice were 
subjected to HFD challenge for 16 weeks, with subsequent DT administration. Both WT 
and CD206DTR mice showed no difference in food intake (Figure 17a) or body weight 
gain (Figure 17b) during the 16 weeks of HFD-fed periods, but decreased weight gain 
was observed in CD206+ M2-like macrophages-reduced mice compared to WT after DT 
administration (Figure 17c). Notably, CD206+ M2-like macrophages-reduced mice 
showed improved glucose tolerance and insulin sensitivity even during HFD-fed 
periods (Figure 18a and 18b). Consistent with this, they showed an increased number of 
smaller adipocytes with a reduced number of CLS compared to the WT control group 
(Figure 18c-e).  
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Figure 17. Effect of CD206+ M2-like macrophages depletion on food 
intake and body weight 
(a) Food intake before and after DT-treated HFD-fed CD206DTR and WT mice. (b) 
Body weights of the WT and CD206DTR mice during 16 weeks of HFD (n=4-6 mice 
per group). (c) Body weights before and after DT administration in the HFD-fed 
CD206DTR and WT mice (n=4-6 mice per group). The data are shown as the means ± 
SEM.  *P < 0.05 compared with littermate by Student's t-test.  
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Figure 18. CD206+ M2-like macrophages depletion promote insulin sensitivity in 
obese mice 
(a) IP-GTT and (b) IP-ITT in 16-week HFD-fed mice after DT treatment (n=5 mice 
per group). (c) HE staining of eWAT (left panel). The number of CLS/field is given in 
right panel. (Scale bar, 200 m). (d) Representative images of a paraffin section of 
eWAT of the DT-treated HFD-fed CD206DTR and WT mice stained with anti-CD11c 
and anti-F4/80 antibody (left panel). The number of F4/80 and CD11c positive 
cells/field (right panel) (n=3-4 mice per group) (Scale bar, 200 m). (e) A histogram of 
adipocyte cell size in the eWAT of DT-treated HFD-fed CD206DTR mice compared 
with WT mice (n=4-5 mice per group). The data are shown as the means ± SEM.  *P 
< 0.05 compared with littermate by Student's t-test.  
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4.11 Hyeperinsulinemic-euglycemic clamp study  
To determine the tissues responsible for amelioration of insulin resistance, we 
performed hyperinsulinemic-euglycemic clamp studies in DT-treated CD206DTR and 
WT mice (Figure 19). We determined that these mice showed significant increments in 
glucose infusion rate (GIR) and rate of whole-body glucose disappearance (Rd) than 
WT control mice without any significant suppressions in hepatic glucose production 
(HGP) (Figure 19), indicating that skeletal muscle/adipose tissues are responsible for 
metabolic improvement.  
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Figure 19. Hyperinsulinemic-euglycemic clamp study  
Hyperinsulinemic-euglycemic clamp study showed glucose infusion rates (GIR), 
hepatic glucose production (HGP), and rate of glucose disappearance (Rd) in HFD-fed 
DT-treated CD206DTR and WT mice (n= 9-10 mice per group).  The data are shown 
as the means ± SEM. *P < 0.05, **P < 0.01 compared with littermate by Student's 
t-test.  
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4.12 Effect of CD206+ M2-like macrophages depletion on M1-like 
macrophages and adipogenesis in eWAT of HFD-fed obese mice 
Flow cytometric analysis further confirmed the reduced macrophage infiltration 
in response to HFD challenge (Figure 20a). The eWAT of CD206+ M2-like 
macrophages-reduced mice showed up-regulated expressions of adipogenesis-related 
transcription factor genes (e.g. C/EBP-α, C/EBP-δ, PPAR), genes that are associated 
with metabolically favorable states (e.g. PGC-1α, PGC-1, Glut4), APs and MSC 
marker genes (e.g. Sca-1, PGDFRα, CD105) and cell cycle-related genes (e.g. Ki-67, 
Cyclin A2, Cyclin B1), along with down-regulation of pro-inflammatory M1 
macrophage markers (e.g. CD11c, MCP1, NOS2, IL-6 and TNF (Figure 20b-d). Thus, 
CD206+ M2-like macrophages play crucial roles in regulating glucose metabolism in 
HFD-fed as well as NC-fed mice.  
104 
 
105 
 
106 
 
Figure 20. Effects of CD206+ M2-like macrophages depletion on adipogenesis and 
macrophage polarization in obese mice 
(a) Representative flow cytometry analysis of CD11c and CD206 expression in F4/80+ 
SVF cells of eWAT from WT and CD206DTR mice. Cells were also stained with 
isotype control antibodies for anti-CD11c and anti-CD206 antibodies (left panel). 
Percentages of M1- and M2-like macrophages in SVF (or F4/80+ SVF) of eWAT from 
WT and CD206DTR mice were calculated (right panel). (b) Relative mRNA 
expression of metabolic genes and (c,d) M1-, M2-like macrophages, adipogenesis, 
APs/MSC and cell cycle markers genes in eWAT of DT-treated HFD-fed CD206DTR 
and WT mice. (n=3-5 per group). The data are shown as the means ± SEM. *P < 0.05, 
** P < 0.01. The data are shown as the means ± SEM.*P<0.05, **P<0.01 compared 
with littermate by Student's t-test.  
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4.13 Depletion of CD206+ M2-like macrophages promotes browning of white 
adipocytes 
Finally, we addressed whether depletion of CD206+ M2-like macrophages affect 
beige progenitors. DT-treated CD206DTR and WT mice after cold exposure for 
seven days resulted in markedly increased expressions of UCP1 as well as other 
browning marker genes in the iWAT [47, 66-68] (Figure 21a). Immunofluoresence 
analysis also revealed increased UCP1 in CD206DTR mice upon cold exposure 
(Figure 21b). Consistent with this, the beige progenitor marker genes were also 
upregulated (Figure 21c). Interestingly, flow cytometry analysis revealed an 
increase in the PDGFRSca-1 double positive cells after cold exposure in the 
iWAT of the CD206DTR mice compared to WT control (Figure 21d and 21e). These 
data suggested that CD206+ M2-like macrophages might be involved in regulating 
the browning of iWAT under cold stimulation. Further studies are required to 
investigate the role M2-like macrophages ablation in regulating the biological 
properties of beige progenitors and how they interact with each other to form niche 
will significantly enrich our knowledge.   
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Figure 21. Depletion of CD206+ M2-like macrophages promotes 
browning of iWAT 
(a) Relative mRNA expression of UCP1, PGC-1. CPT-1and CD137 levels in iWAT 
after CD206+ M2-like macrophages depletion under cold exposure (6°C) (n=3-5 mice 
per group). (b) Immunofluoresence analysis of paraffin section of the eWAT stained 
with anti-UCP1 antibody in DT-treated CD206DTR mice after cold exposure compared 
with WT control. The images were taken with a Leica TCS-SP5 (40x). (c) 
Representative flow cytometry analysis of PDGFRSca-1 double positive cells from 
iWAT of DT-treated CD206DTR and WT mice at RT  and cold stimulated (25°C and 
6°C) (left panel). The percentage of Lin(-)APs positive fraction  in the DT-treated 
CD206DTR mice are shown in the right panel (n=3-5). For this, first, negative selection 
of PE-Cy7 anti CD31 (endothelial), FITC anti-mouse lineage cocktail were selected 
followed by positive selection of PE anti-PDGFR and APC-Cy7 anti Sca-1. The data 
are shown as the means ± SEM. *P< 0.05 compared with littermate by Student's t-test.  
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5.0 Discussion 
Several lines of evidence have suggested that ATMs are involved in maintaining insulin 
sensitivity in adipocytes through their anti-inflammatory actions, in collaboration with 
other leukocyte lineages including Treg cells, eosinophils, and invariant natural killer 
cells [1, 2, 4, 17, 47]. In the current study, we determined that CD206 is an ideal marker 
to target M2-like macrophages in adipose tissues. Thus, we are able to specifically 
deplete M2-polarized macrophages in adipose tissue of DT-treated CD206DTR mice. 
So far, congenital deficiency of M2-like macrophages reportedly causes 
lipodystrophy-like pathophysiology accompanied by accelerated lipolysis [12]. As 
insulin resistance and obesity related disorders progresses with advanced age, and 
M2-like macrophages are up-regulated in the early phases of obesity [13], it is 
important to deplete M2-like macrophages at a specific time point to examine the 
developmentally time sensitive role of M2-like macrophages. Thus, conditional and 
partial depletion have advantages over congenital or genetic ablation of M2-like 
macrophages. There are a number of reports demonstrating that partial and conditional 
depletion of specific cell lineages can bring about particular biological events without 
affecting the functions of other cells lineages [69-73]. In this study, we have 
successfully shown that partial but specific depletion of CD206+ M2-like macrophages 
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in adult mice improved glucose metabolism without affecting body weight, food intake, 
and the numbers and functions of other cell lineages, including M1 macrophages 
(Figure 22).  
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Previous studies show that genetic disruption of functions or numbers of M2-like 
macrophages reduces the ability of M2-like macrophages to recruit the APs. Genetic 
disruption of functions or numbers of M2-like macrophages reduces the ability of 
M2-like macrophages to recruit APs. Previous studies indicated that PDGFR+ 
progenitors were recruited in WAT upon ADRB3 stimulation (Lee et al., 2012) and these 
APs were also involved in different compensatory mechanism involving cellular 
restoration and repair in WAT and other tissues (Lee et al., 2013; Uezumi et al., 2010). 
In contrast, compromised functions of macrophages due to genetic disruption of genes 
regulating the macrophages activity cause insulin resistance and other metabolic 
disorders as observed in Trib1-/- phenotype mice (Satoh et al., 2013). While in our study, 
conditional or transient depletion of M2-like macrophages depletion enhances the 
ability of M2-like macrophages to recruit APs that shift the adipose tissue towards a 
smaller and insulin sensitive adipocytes (Figure 23). 
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It has been reported that cold stimulation promotes the differentiation of beige 
precursors into beige/brite adipocytes within one week of exposure [67, 74]. There 
are several reports indicating that M2 macrophages polarization regulates 
thermogenesis and browning of iWAT by increasing the expression of UCP1, 
PGC-1 and other browning genes [2, 16, 75]. Previous studies indicated that 
PDGFR+ progenitors were recruited in WAT upon ADRB3 stimulation [11] and 
these APs were also involved in different compensatory mechanism involving 
cellular restoration and repair in WAT and other tissues [3, 76]. M2-like 
macrophages play key role in shifting of browning into WAT via activation of type 2 
cytokines during cold exposure. In WAT, eosinophils and M2-like macrophages are 
known to promote glucose homeostasis through the activation of type 2 innate 
lymphoid cells results in browning of WAT [47, 77]. Chronic cold exposure also 
enhances percentage of M2-like macrophages in WAT, suggesting that cold 
stimulation modulate M2-like macrophages within WAT to promote browning of 
WAT. Previous reports show that type 2 cytokines and ATMs were involved in 
regulation of APs remodeling [3, 16, 47, 68]. While our study shows that depletion 
of CD206 M2-like macrophages promotes the browning of white adipose tissue. 
Our study shows the expressions of UCP1 and other browning related genes were 
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significantly upregulated after depletion of CD206 M2-like macrophages, 
suggesting that depletion CD206 M2-like macrophages promote browning of WAT 
(Figure 24). Our findings suggest that CD206/TGFβ signaling play a critical role in 
maintaining APs in a quiescent state in an analogous manner to that of the 
non-myelinating Schwann cell-based niche, where hematopoietic stem cells (HSCs) 
are maintained in hibernation via TGFβ-dependent pathways [38].  
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As we have previously reported, M2-like macrophages expand, albeit mildly 
compared to M1-like macrophages, during the course of obesity progression [13]. 
Therefore, it may be possible that the mild expansion of M2-like macrophages 
during the progression of obesity hampers APs proliferation and subsequent 
adipogenesis. Thus, the limited adipogenesis due to expanded M2-like macrophages 
may increase the lipid burden of the existing fat cells, inducing hypertrophy rather 
than hyperplasia of adipose tissues, thus impairing insulin resistance. A series of 
these events may create a vicious cycle, accelerating the progression of 
obesity-associated metabolic disorders. In this regard, it is expected that CD206+ 
M2-like macrophage-targeting drugs may exert effective therapeutic effects by 
breaking the vicious cycle between M2-like macrophages and APs. Since reduction 
of CD206+ M2-like macrophages did not affect systemic adiposity, CD206+ M2-like 
ATMs-targeting drugs would not promote obesity, as is observed in the case of 
PPAR activators (e.g. thiazolidinedione). The findings that systemic insulin 
resistance is ameliorated by M1-macrophage depletion and aggravated by adoptive 
transfer of M2- to M1-like macrophages cells strongly suggest that CD206+ M2-like 
macrophages are regarded as anti-inflammatory cells and has an impact on systemic 
metabolism [10, 18, 37, 78]. We, however, obtained reverse results showing that 
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depletion of CD206+ M2-like macrophages resulted in improved glucose tolerance 
rather than worsening glucose metabolism. We demonstrated that CD206+ M2-like 
macrophages may be responsible to regulate insulin resistance and metabolic 
disorders indicating that M2-like macrophages itself does not furnish insulin 
sensitivity but just a reflection of favorable environment. This finding led us to look 
for other homeostatic functions of M2-like macrophages than previously reported 
their anti-inflammatory function. These data suggested that CD206+ M2-like 
macrophages in adipose tissue inhibit uncontrolled proliferation of APs and 
excessive differentiation into mature adipocytes. 
So far how AP’s proliferation and their differentiation into mature adipocyte in 
vivo is regulated is largely unknown. Our data demonstrated that adipose tissue M2-like 
macrophage is able to keep APs in a hibernating state to inhibit excessive proliferation. 
This is somewhat similar to the previous report that non-myelinating Schwann cells 
inhibit the growth of HSCs in the bone marrow by activating TGFβ pathways [38] in the 
bone marrow by activating TGFβ pathways. Like an HSCs riche in the bone marrow, it 
may be possible that CD206+ M2-like macrophages form a niche for APs, thus 
maintaining the number of APs and matured adipocyte by inhibiting the proliferation of 
progenitors. When the function of CD206+ M2-like macrophages is abruptly 
121 
 
compromised, the progenitor activation and differentiation into adipocytes occur. 
Recently, Lee and Granneman reported that β3-agonist treatment early several days 
resulted in adipocyte cell death, engulfment of all debris by macrophages which express 
the canonical markers of alternatively activated macrophages (AAMs), and recruitment 
of PDGFRα(+) APs [16, 79]. 
Previous reports have shown that signals or stimuli that activate alternative 
activation such as extrinsic eosinophil-IL-4/-13 pathway and intrinsic PPARγ, STAT6 
pathway improve adipocyte function, thus leading to insulin sensitivity. Most of the 
experiments were performed under HFD conditions and demonstrated that AAMs play a 
role in metabolic adaptations to excessive nutrient intake through anti-inflammatory 
functions. How should our results be reconciled with preciously reported data? First, 
most of the experiments were conducted on HFD condition, and adipose tissue resident 
macrophages may be required for metabolic adaptations to excessive nutrient intake. 
Second, almost all the previous reports utilized mice with genetic disruption of genes 
involved in alternative activation pathway. Those mice have some adaptation during 
both development and post-natal stage. 
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Our study demonstrated that CD206+ M2-like macrophages cells inhibit APs 
proliferation and differentiation into adipocytes in a TGFβ-dependent manner. Further 
research evidences are required to expand and identify the role of TGF in controlling 
the progenitor proliferation.  
In HFD-fed mice, both CD11c+CD206- and CD11c+CD206+ ATMs are markedly 
increased; DT-treatment depleted not only CD206+CD11c- but also CD206+CD11c+ 
ATMs. Although it seems that CD206+ M2-like macrophages plays a major role in the 
insulin-sensitive phenotype associated with reduced inflammation, the possibility that 
depletion of CD206+CD11c+ ATMs contributes to this phenotype may not completely be 
excluded. The biological significance CD206+ M2-like macrophages-induced inhibition 
of APs proliferation includes (i) recruitment of APs and provide a sufficient APs pool to 
store excess energy, thus inhibiting the development of lipodystrophic diabetes, (ii) 
inhibition of unnecessary division of APs to attenuate cellular senescence (to keep the 
APs young and to make them hibernated), and (iii) the identification of CD206+ M2-like 
macrophages-APs interactions as therapeutic target for the treatment of insulin 
resistance and type 2 diabetes.  
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5.1 Conclusion 
In conclusion, the current study demonstrates a new role for CD206+ M2-like 
macrophages in constituting a microenvironment for APs, in a TGFβ-dependent 
manner, to retain systemic insulin sensitivity by tuning the quiescence/proliferation 
balance of APs to adapt to changes in nutritional status (Figure 25). Our findings 
suggest a new strategy for the development of drug discovery for the treatment of 
insulin resistance and type 2 diabetes. 
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Figure 25. Schematic diagram of summary of effect of depletion of CD206+ M2-like 
macrophages  
Depletion of CD206+ M2-like macrophages induces adipocyte progenitor`s proliferation 
and promote insulin sensitivity. On the other hand, upon cold stimulation, depletion of 
CD206+ M2-like macrophages promotes browning of white adipose tissue and induces 
insulin sensitivity. 
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Note; 
This thesis is written on the basis of recently published article as given below; 
Nawaz A, Aminuddin A, Kado T, Takikawa A, Yamamoto S, Tsuneyama 
K, Igarashi Y, Ikutani M, Nishida Y, Nagai Y, Takatsu K, Imura J, 
Sasahara M, Okazaki Y, Ueki K, Okamura T, Tokuyama K, Ando A, 
Matsumoto M, Mori H, Nakagawa T, Kobayashi N, Saeki K, Usui I, 
Fujisaka S, Tobe K. CD206+ M2-like macrophages regulate glucose 
metabolism by inhibiting proliferation of adipocyte progenitors. Nature 
Communications., 8(1); 286, August 18, 2017. (IF=12.124)
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